Инвестиции в таблетки: сколько можно заработать? || Вредные беседы

While the market is turbulent, Ozon Pharmaceuticals is showing unusual resilience. Why is this business growing faster than the Russian economy? We explore the company's inner workings: from the actual cost of its medications to its ambitions in biotech and government contracts. We explore how the company will make money in 2026 and where the limits of this growth lie. Support the harmful: Our TG — https://t.me/+Y94FkGO7GEZlNjdi Murad's TG — https://t.me/+T_wjedb4X0E2NWEy We're on VKontakte — https://vk.com/harmfulinvestor Harmful Investor Club — https://clck.ru/3T3B7u Donations to Boosty — https://boosty.to/harmfulinvestor/donate Link to the Black Line Mutual Fund: https://clck.ru/3TMavK Time Codes: 00:00 Start 00:15 Sber or Ozon Pharmaceuticals? 7:41 AM 2025 Results and 2026 Forecasts 3:34 PM Biotech Development 10:38 PM Working with the Pharmaceutical Community 27:29 PM Export Ambitions 36:58 PM Virtual Factory Tour Thanks to Dmitry Kovalenko for the conversation! More videos from the "Harmful Conversations" section: •    • Куда пропадала Европейская Электротехника?...   •    • Базис: IPO, рост прибыли, рынок IT || Вред...   #pharma #ozonpharmaceuticals #investments #business